276.98 USD
▼-3.67-1.31%
盘后 281.00 +1.45%
2026-09-15
市值
$5.52B
市盈率
30.13
EPS
9.19
股息率
—
52 周区间
161.82 – 326.63
成交量
180.22K
Beta
0.98
目标价
342.82
52W 低 161.8252W 高 326.63
价格走势
公司简介
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteopor...